Lista de obras - Christina Möller-Koop - Dominio Público Uruguay

13q deletion is linked to an adverse phenotype and poor prognosis in prostate cancer

artículo científico publicado en 2018

5q21 deletion is often heterogeneous in prostate cancer

scientific article published on 24 January 2019

8p deletions in renal cell carcinoma are associated with unfavorable tumor features and poor overall survival

artículo científico publicado en 2019

A non-diploid DNA status is linked to poor prognosis in renal cell cancer

scientific article published on 02 May 2020

A shift from membranous and stromal syndecan-1 (CD138) expression to cytoplasmic CD138 expression is associated with poor prognosis in breast cancer

artículo científico publicado en 2019

Aberrant expression of membranous carbonic anhydrase IX (CAIX) is associated with unfavorable disease course in papillary and clear cell renal cell carcinoma

scientific article published on 12 October 2018

Apurinic/apyrimidinic endonuclease 1 (APE1/Ref-1) overexpression is an independent prognostic marker in prostate cancer without TMPRSS2:ERG fusion.

artículo científico publicado en 2017

Aquaporin 5 expression is frequent in prostate cancer and shows a dichotomous correlation with tumor phenotype and PSA recurrence

artículo científico publicado en 2015

Chromosomal deletion of 9p21 is linked to poor patient prognosis in papillary and clear cell kidney cancer

artículo científico publicado en 2020

Chromosome 17p13 deletion is associated with an aggressive tumor phenotype in clear cell renal cell carcinoma

artículo científico publicado en 2020

Clinical significance of different types of p53 gene alteration in surgically treated prostate cancer

artículo científico publicado en 2014

Correction: Genomic deletion of chromosome 12p is an independent prognostic marker in prostate cancer

artículo científico publicado en 2017

Cytoplasmic Accumulation of Sequestosome 1 (p62) Is a Predictor of Biochemical Recurrence, Rapid Tumor Cell Proliferation, and Genomic Instability in Prostate Cancer

artículo científico publicado en 2015

Cytoplasmic accumulation of ELAVL1 is an independent predictor of biochemical recurrence associated with genomic instability in prostate cancer

scientific article published on 02 November 2015

Deletion lengthening at chromosomes 6q and 16q targets multiple tumor suppressor genes and is associated with an increasingly poor prognosis in prostate cancer

artículo científico publicado en 2017

Deletion of 18q is a strong and independent prognostic feature in prostate cancer

artículo científico publicado en 2016

Deletion of 3p13 is a late event linked to progression of : fusion prostate cancer

Deletion of 8p is an independent prognostic parameter in prostate cancer

artículo científico publicado en 2016

Detection of the single hotspot mutation in the JH2 pseudokinase domain of Janus kinase 2 in bone marrow trephine biopsies derived from chronic myeloproliferative disorders

artículo científico

Determination of Tumor Heterogeneity in Colorectal Cancers Using Heterogeneity Tissue Microarrays

artículo científico publicado en 2015

Diverse expression patterns of the EMT suppressor grainyhead-like 2 (GRHL2) in normal and tumour tissues

artículo científico

Down-Regulation of S100A8 is an Independent Predictor of PSA Recurrence in Prostate Cancer Treated by Radical Prostatectomy

scientific article published on 02 August 2019

Expression of DNA ligase IV is linked to poor prognosis and characterizes a subset of prostate cancers harboring TMPRSS2:ERG fusion and PTEN deletion

artículo científico publicado en 2015

Family with sequence similarity 13C (FAM13C) overexpression is an independent prognostic marker in prostate cancer

artículo científico publicado en 2017

Genomic deletion of chromosome 12p is an independent prognostic marker in prostate cancer

artículo científico publicado en 2015

HDAC1 overexpression independently predicts biochemical recurrence and is associated with rapid tumor cell proliferation and genomic instability in prostate cancer.

artículo científico publicado en 2015

HOXB13 overexpression is an independent predictor of early PSA recurrence in prostate cancer treated by radical prostatectomy

artículo científico publicado en 2015

High BCAR1 expression is associated with early PSA recurrence in ERG negative prostate cancer

artículo científico publicado en 2018

High concordance of TMPRSS-ERG fusion between primary prostate cancer and its lymph node metastases

High concordance of findings obtained from transgluteal magnetic resonance imaging - and transrectal ultrasonography-guided biopsy as compared with prostatectomy specimens

artículo científico publicado en 2017

High lysophosphatidylcholine acyltransferase 1 expression independently predicts high risk for biochemical recurrence in prostate cancers

artículo científico publicado en 2013

High mitochondria content is associated with prostate cancer disease progression

artículo científico publicado en 2013

High-Level Glyoxalase 1 (GLO1) expression is linked to poor prognosis in prostate cancer.

artículo científico publicado en 2017

High-Level HOOK3 Expression Is an Independent Predictor of Poor Prognosis Associated with Genomic Instability in Prostate Cancer

artículo científico publicado en 2015

High-Level γ-Glutamyl-Hydrolase (GGH) Expression is Linked to Poor Prognosis in ERG Negative Prostate Cancer

artículo científico publicado en 2017

High-level expression of protein tyrosine phosphatase non-receptor 12 is a strong and independent predictor of poor prognosis in prostate cancer

artículo científico publicado en 2019

IMP3 overexpression occurs in various important cancer types and is linked to aggressive tumor features: A tissue microarray study on 8,877 human cancers and normal tissues

artículo científico publicado en 2017

Immunohistochemically detected IDH1R132H mutation is rare and mostly heterogeneous in prostate cancer

artículo científico publicado en 2018

Integrating Tertiary Gleason 5 Patterns into Quantitative Gleason Grading in Prostate Biopsies and Prostatectomy Specimens.

artículo científico publicado en 2017

Intratumor DNA methylation heterogeneity reflects clonal evolution in aggressive prostate cancer.

artículo científico publicado en 2014

Loss of SOX9 Expression Is Associated with PSA Recurrence in ERG-Positive and PTEN Deleted Prostate Cancers

artículo científico publicado en 2015

Loss of cytoplasmic survivin expression is an independent predictor of poor prognosis in radically operated prostate cancer patients

artículo científico publicado en 2020

MALDI mass spectrometric imaging based identification of clinically relevant signals in prostate cancer using large-scale tissue microarrays.

artículo científico publicado en 2013

Marked Prognostic Impact of Minimal Lymphatic Tumor Spread in Prostate Cancer

artículo científico publicado en 2018

Mass Spectrometric Comparison of HPV-Positive and HPV-Negative Oropharyngeal Cancer

artículo científico publicado en 2020

Molecular Evolution of Early-Onset Prostate Cancer Identifies Molecular Risk Markers and Clinical Trajectories

artículo científico publicado en 2018

NY-ESO-1 expression is tightly linked to TMPRSS2-ERG fusion in prostate cancer

artículo científico publicado en 2014

Overexpression of enhancer of zeste homolog 2 (EZH2) characterizes an aggressive subset of prostate cancers and predicts patient prognosis independently from pre- and postoperatively assessed clinicopathological parameters

artículo científico publicado en 2015

Overexpression of thymidylate synthase (TYMS) is associated with aggressive tumor features and early PSA recurrence in prostate cancer

artículo científico publicado en 2015

PSCA expression is associated with favorable tumor features and reduced PSA recurrence in operated prostate cancer.

artículo científico publicado en 2018

PTEN loss detection in prostate cancer: comparison of PTEN immunohistochemistry and PTEN FISH in a large retrospective prostatectomy cohort

artículo científico publicado en 2017

Prevalence and clinical significance of VHL mutations and 3p25 deletions in renal tumor subtypes

artículo científico publicado en 2020

Prevalence of Syndecan-1 (CD138) Expression in Different Kinds of Human Tumors and Normal Tissues

scientific article published on 23 December 2019

Prevalence of βIII-tubulin (TUBB3) expression in human normal tissues and cancers

artículo científico publicado en 2017

Prognostic and diagnostic role of PSA immunohistochemistry: A tissue microarray study on 21,000 normal and cancerous tissues

artículo científico publicado en 2019

Qualitative and Quantitative Requirements for Assessing Prognostic Markers in Prostate Cancer

artículo científico publicado en 2014

Reduced AZGP1 expression is an independent predictor of early PSA recurrence and associated with ERG-fusion positive and PTEN deleted prostate cancers

artículo científico publicado en 2015

Reduced RBM3 expression is associated with aggressive tumor features in esophageal cancer but not significantly linked to patient outcome

artículo científico publicado en 2018

Saccharomyces cerevisiae-like 1 overexpression is frequent in prostate cancer and has markedly different effects in Ets-related gene fusion-positive and fusion-negative cancers

artículo científico publicado en 2014

Secreted Frizzled-Related Protein 4 (SFRP4) Is an Independent Prognostic Marker in Prostate Cancers Lacking TMPRSS2: ERG Fusions

scientific article published on 16 July 2020

TMPRSS2-ERG fusions are strongly linked to young patient age in low-grade prostate cancer

artículo científico publicado en 2014

The Combination of DNA Ploidy Status and PTEN/6q15 Deletions Provides Strong and Independent Prognostic Information in Prostate Cancer

artículo científico publicado en 2016

The prognostic impact of high Nijmegen breakage syndrome (NBS1) gene expression in ERG-negative prostate cancers lacking PTEN deletion is driven by KPNA2 expression.

artículo científico publicado en 2014

The prognostic value of SUMO1/Sentrin specific peptidase 1 (SENP1) in prostate cancer is limited to ERG-fusion positive tumors lacking PTEN deletion

artículo científico publicado en 2015

Up regulation of the steroid hormone synthesis regulator HSD3B2 is linked to early PSA recurrence in prostate cancer

artículo científico publicado en 2018

Up-regulation of mismatch repair genes MSH6, PMS2 and MLH1 parallels development of genetic instability and is linked to tumor aggressiveness and early PSA recurrence in prostate cancer

artículo científico publicado en 2016

Upregulation of Phosphatase 1 Nuclear-Targeting Subunit (PNUTS) Is an Independent Predictor of Poor Prognosis in Prostate Cancer

scientific article published on 25 April 2020

Upregulation of SPDEF is associated with poor prognosis in prostate cancer

artículo científico publicado en 2019

Upregulation of centromere protein F is linked to aggressive prostate cancers

Upregulation of the transcription factor TFAP2D is associated with aggressive tumor phenotype in prostate cancer lacking the TMPRSS2:ERG fusion

scientific article published on 06 March 2020

VEGFR-1 overexpression identifies a small subgroup of aggressive prostate cancers in patients treated by prostatectomy

artículo científico publicado en 2015

p16 overexpression and 9p21 deletion are linked to unfavorable tumor phenotype in breast cancer

artículo científico publicado en 2016

p16 upregulation is linked to poor prognosis in ERG negative prostate cancer.

artículo científico publicado en 2016

βIII-tubulin overexpression is linked to aggressive tumor features and genetic instability in urinary bladder cancer

artículo científico publicado en 2016

βIII-tubulin overexpression is linked to aggressive tumor features and shortened survival in clear cell renal cell carcinoma

artículo científico publicado en 2014

Lista de obras de Christina Möller-Koop

13q deletion is linked to an adverse phenotype and poor prognosis in prostate cancer

5q21 deletion is often heterogeneous in prostate cancer

8p deletions in renal cell carcinoma are associated with unfavorable tumor features and poor overall survival

A non-diploid DNA status is linked to poor prognosis in renal cell cancer

A shift from membranous and stromal syndecan-1 (CD138) expression to cytoplasmic CD138 expression is associated with poor prognosis in breast cancer

Aberrant expression of membranous carbonic anhydrase IX (CAIX) is associated with unfavorable disease course in papillary and clear cell renal cell carcinoma

Apurinic/apyrimidinic endonuclease 1 (APE1/Ref-1) overexpression is an independent prognostic marker in prostate cancer without TMPRSS2:ERG fusion.

Aquaporin 5 expression is frequent in prostate cancer and shows a dichotomous correlation with tumor phenotype and PSA recurrence

Chromosomal deletion of 9p21 is linked to poor patient prognosis in papillary and clear cell kidney cancer

Chromosome 17p13 deletion is associated with an aggressive tumor phenotype in clear cell renal cell carcinoma

Clinical significance of different types of p53 gene alteration in surgically treated prostate cancer

Correction: Genomic deletion of chromosome 12p is an independent prognostic marker in prostate cancer

Cytoplasmic Accumulation of Sequestosome 1 (p62) Is a Predictor of Biochemical Recurrence, Rapid Tumor Cell Proliferation, and Genomic Instability in Prostate Cancer

Cytoplasmic accumulation of ELAVL1 is an independent predictor of biochemical recurrence associated with genomic instability in prostate cancer

Deletion lengthening at chromosomes 6q and 16q targets multiple tumor suppressor genes and is associated with an increasingly poor prognosis in prostate cancer

Deletion of 18q is a strong and independent prognostic feature in prostate cancer

Deletion of 3p13 is a late event linked to progression of : fusion prostate cancer

Deletion of 8p is an independent prognostic parameter in prostate cancer

Detection of the single hotspot mutation in the JH2 pseudokinase domain of Janus kinase 2 in bone marrow trephine biopsies derived from chronic myeloproliferative disorders

Determination of Tumor Heterogeneity in Colorectal Cancers Using Heterogeneity Tissue Microarrays

Diverse expression patterns of the EMT suppressor grainyhead-like 2 (GRHL2) in normal and tumour tissues

Down-Regulation of S100A8 is an Independent Predictor of PSA Recurrence in Prostate Cancer Treated by Radical Prostatectomy

Expression of DNA ligase IV is linked to poor prognosis and characterizes a subset of prostate cancers harboring TMPRSS2:ERG fusion and PTEN deletion

Family with sequence similarity 13C (FAM13C) overexpression is an independent prognostic marker in prostate cancer

Genomic deletion of chromosome 12p is an independent prognostic marker in prostate cancer

HDAC1 overexpression independently predicts biochemical recurrence and is associated with rapid tumor cell proliferation and genomic instability in prostate cancer.

HOXB13 overexpression is an independent predictor of early PSA recurrence in prostate cancer treated by radical prostatectomy

High BCAR1 expression is associated with early PSA recurrence in ERG negative prostate cancer

High concordance of TMPRSS-ERG fusion between primary prostate cancer and its lymph node metastases

High concordance of findings obtained from transgluteal magnetic resonance imaging - and transrectal ultrasonography-guided biopsy as compared with prostatectomy specimens

High lysophosphatidylcholine acyltransferase 1 expression independently predicts high risk for biochemical recurrence in prostate cancers

High mitochondria content is associated with prostate cancer disease progression

High-Level Glyoxalase 1 (GLO1) expression is linked to poor prognosis in prostate cancer.

High-Level HOOK3 Expression Is an Independent Predictor of Poor Prognosis Associated with Genomic Instability in Prostate Cancer

High-Level γ-Glutamyl-Hydrolase (GGH) Expression is Linked to Poor Prognosis in ERG Negative Prostate Cancer

High-level expression of protein tyrosine phosphatase non-receptor 12 is a strong and independent predictor of poor prognosis in prostate cancer

IMP3 overexpression occurs in various important cancer types and is linked to aggressive tumor features: A tissue microarray study on 8,877 human cancers and normal tissues

Immunohistochemically detected IDH1R132H mutation is rare and mostly heterogeneous in prostate cancer

Integrating Tertiary Gleason 5 Patterns into Quantitative Gleason Grading in Prostate Biopsies and Prostatectomy Specimens.

Intratumor DNA methylation heterogeneity reflects clonal evolution in aggressive prostate cancer.

Loss of SOX9 Expression Is Associated with PSA Recurrence in ERG-Positive and PTEN Deleted Prostate Cancers

Loss of cytoplasmic survivin expression is an independent predictor of poor prognosis in radically operated prostate cancer patients

MALDI mass spectrometric imaging based identification of clinically relevant signals in prostate cancer using large-scale tissue microarrays.

Marked Prognostic Impact of Minimal Lymphatic Tumor Spread in Prostate Cancer

Mass Spectrometric Comparison of HPV-Positive and HPV-Negative Oropharyngeal Cancer

Molecular Evolution of Early-Onset Prostate Cancer Identifies Molecular Risk Markers and Clinical Trajectories

NY-ESO-1 expression is tightly linked to TMPRSS2-ERG fusion in prostate cancer

Overexpression of enhancer of zeste homolog 2 (EZH2) characterizes an aggressive subset of prostate cancers and predicts patient prognosis independently from pre- and postoperatively assessed clinicopathological parameters

Overexpression of thymidylate synthase (TYMS) is associated with aggressive tumor features and early PSA recurrence in prostate cancer

PSCA expression is associated with favorable tumor features and reduced PSA recurrence in operated prostate cancer.

PTEN loss detection in prostate cancer: comparison of PTEN immunohistochemistry and PTEN FISH in a large retrospective prostatectomy cohort

Prevalence and clinical significance of VHL mutations and 3p25 deletions in renal tumor subtypes

Prevalence of Syndecan-1 (CD138) Expression in Different Kinds of Human Tumors and Normal Tissues

Prevalence of βIII-tubulin (TUBB3) expression in human normal tissues and cancers

Prognostic and diagnostic role of PSA immunohistochemistry: A tissue microarray study on 21,000 normal and cancerous tissues

Qualitative and Quantitative Requirements for Assessing Prognostic Markers in Prostate Cancer

Reduced AZGP1 expression is an independent predictor of early PSA recurrence and associated with ERG-fusion positive and PTEN deleted prostate cancers

Reduced RBM3 expression is associated with aggressive tumor features in esophageal cancer but not significantly linked to patient outcome

Saccharomyces cerevisiae-like 1 overexpression is frequent in prostate cancer and has markedly different effects in Ets-related gene fusion-positive and fusion-negative cancers

Secreted Frizzled-Related Protein 4 (SFRP4) Is an Independent Prognostic Marker in Prostate Cancers Lacking TMPRSS2: ERG Fusions

TMPRSS2-ERG fusions are strongly linked to young patient age in low-grade prostate cancer

The Combination of DNA Ploidy Status and PTEN/6q15 Deletions Provides Strong and Independent Prognostic Information in Prostate Cancer

The prognostic impact of high Nijmegen breakage syndrome (NBS1) gene expression in ERG-negative prostate cancers lacking PTEN deletion is driven by KPNA2 expression.

The prognostic value of SUMO1/Sentrin specific peptidase 1 (SENP1) in prostate cancer is limited to ERG-fusion positive tumors lacking PTEN deletion

Up regulation of the steroid hormone synthesis regulator HSD3B2 is linked to early PSA recurrence in prostate cancer

Up-regulation of mismatch repair genes MSH6, PMS2 and MLH1 parallels development of genetic instability and is linked to tumor aggressiveness and early PSA recurrence in prostate cancer

Upregulation of Phosphatase 1 Nuclear-Targeting Subunit (PNUTS) Is an Independent Predictor of Poor Prognosis in Prostate Cancer

Upregulation of SPDEF is associated with poor prognosis in prostate cancer

Upregulation of centromere protein F is linked to aggressive prostate cancers

Upregulation of the transcription factor TFAP2D is associated with aggressive tumor phenotype in prostate cancer lacking the TMPRSS2:ERG fusion

VEGFR-1 overexpression identifies a small subgroup of aggressive prostate cancers in patients treated by prostatectomy

p16 overexpression and 9p21 deletion are linked to unfavorable tumor phenotype in breast cancer

p16 upregulation is linked to poor prognosis in ERG negative prostate cancer.

βIII-tubulin overexpression is linked to aggressive tumor features and genetic instability in urinary bladder cancer

βIII-tubulin overexpression is linked to aggressive tumor features and shortened survival in clear cell renal cell carcinoma